The Chinese medical regulatory writing and medical science writing landscapes are chang - ing rapidly. Changes in regulatory reforms continue as China further strives to align its pharmaceutical industry with the world, which necessitates collaborative writers who are capable of keeping up with both changes in regulations and innovative medicine. Medical science writing is dependent on the adaptation of the material to suit Chinese media platforms. Despite the vast differences in regulatory writing and medical science writing, the essential skills are similar – under - standing data and knowing one’s audience.